• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Chemical Profile of 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine (CAS No. 885-89-2)

8-methyl-2-phenyl-Imidazo[1,2-a]pyridine, identified by its Chemical Abstracts Service (CAS) number 885-89-2, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This bicyclic structure, consisting of an imidazole ring fused with a pyridine moiety, is characterized by the presence of a methyl group at the 8-position and a phenyl group at the 2-position. The unique arrangement of these functional groups imparts distinct chemical and pharmacological properties, making it a valuable scaffold for the development of novel therapeutic agents.

The compound belongs to the broader class of imidazopyridines, which have been extensively studied for their potential biological activities. Imidazopyridines are known for their ability to interact with various biological targets, including enzymes and receptors, which makes them promising candidates for drug discovery. The specific substitution pattern in 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine enhances its binding affinity and selectivity, which are critical factors in the design of effective pharmaceuticals.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the binding interactions of 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine with biological targets with high precision. These studies have revealed that the compound exhibits favorable interactions with proteins involved in inflammatory pathways, suggesting its potential as an anti-inflammatory agent. Furthermore, the phenyl group at the 2-position contributes to hydrophobic interactions, which can be leveraged to improve drug solubility and bioavailability.

In vitro studies have demonstrated that 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine possesses inhibitory activity against certain kinases and transcription factors. For instance, research has shown that this compound can modulate the activity of Janus kinases (JAKs), which are implicated in various inflammatory and autoimmune diseases. The ability to regulate JAK activity makes 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine a compelling candidate for further investigation in the treatment of conditions such as rheumatoid arthritis and psoriasis.

The synthesis of 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity. These techniques not only enhance the efficiency of synthesis but also allow for the introduction of additional functional groups, enabling the creation of derivative compounds with tailored biological activities.

One of the key advantages of 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine is its structural flexibility, which allows for modifications at various positions on the heterocyclic core. This flexibility has been exploited by medicinal chemists to develop libraries of analogs with enhanced potency and reduced toxicity. High-throughput screening (HTS) techniques have been instrumental in identifying promising derivatives from these libraries, streamlining the drug discovery process.

Preclinical studies have provided valuable insights into the pharmacokinetic properties of 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine. These studies indicate that the compound exhibits moderate oral bioavailability and a reasonable half-life in vivo. Additionally, preliminary toxicology assessments have shown that 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine is well-tolerated at therapeutic doses, although further studies are needed to fully characterize its safety profile.

The growing interest in 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine has spurred collaborative efforts between academic institutions and pharmaceutical companies. These collaborations aim to accelerate the translation of preclinical findings into clinical trials for therapeutic applications. The compound's potential as an anti-inflammatory agent has particularly attracted attention from researchers working on chronic inflammatory diseases.

Future research directions for 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine include exploring its mechanism of action in greater detail and investigating its efficacy in animal models of disease. Advances in metabolomics and proteomics are expected to provide deeper insights into how this compound interacts with biological systems at a molecular level. Such information will be crucial for optimizing its therapeutic potential and developing combination therapies that synergize with existing treatments.

The development of 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine exemplifies the importance of interdisciplinary approaches in modern drug discovery. By integrating knowledge from chemistry, biology, and pharmacology, researchers can uncover novel therapeutic opportunities that might otherwise remain untapped. As our understanding of disease mechanisms continues to evolve, compounds like 8-methyl-2-phenyl-Imidazo[1,2-a]pyridine will play an increasingly vital role in addressing unmet medical needs.

• 4105-21-9(2-phenylimidazo1,2-apyridine)
• 1019-89-2(6-methyl-2-phenylimidazo[1,2-a]pyridine)
• 3323-66-8(Imidazo[1,2-a]pyridine,2-phenyl-, hydrobromide (1:1))
• 65964-60-5(2-(4-methylphenyl)imidazo[1,2-a]pyridine)
• 88965-00-8(6-methyl-2-(4-methylphenyl)imidazo1,2-apyridine)
• 1338248-70-6(6-methyl-3-phenyl-Imidazo[1,2-a]pyridine)
• 92961-15-4(3-Phenylimidazo1,2-Apyridine)
• 177962-27-5(8-methyl-3-phenyl-Imidazo[1,2-a]pyridine)
• 75318-68-2(Imidazo[2,1-a]isoquinoline, 2-[1,1'-biphenyl]-4-yl-)
• 70845-68-0(Imidazo[2,1-a]isoquinoline,2-phenyl-)